Navigation Links
Breakthrough in treatment to prevent blindness
Date:12/21/2011

A UCSF study shows a popular treatment for a potentially blinding eye infection is just as effective if given every six months versus annually. This randomized study on trachoma, the leading cause of infection-caused blindness in the world, could potentially treat twice the number of patients using the same amount of medication.

"The idea is we can do more with less," said Bruce Gaynor, MD, assistant professor of ophthalmology at the Francis I. Proctor Foundation for Research in Ophthalmology. "We are trying to get as much out of the medicine as we can because of the cost and the repercussions of mass treatments."

In a paper published this month in The Lancet, researchers conducted a cluster-randomized trial, using an antibiotic called azithromycin to treat trachoma in Ethiopia, which has among the highest prevalence in the world. They picked 24 communities and randomized the two treatment options: 12 villages were given azithromycin every six months and the other 12 were treated every 12 months.

"What we found was the prevalence of trachoma is very high at baseline. Forty to 50 percent of the children in these communities have this condition," Gaynor said. "They are the most susceptible and it can quickly spread from person to person by direct or even indirect contact."

Researchers tracked both groups and found the prevalence of infection decreased dramatically.

"We found that from as high as 40 percent, the prevalence of trachoma went way down, even eliminated in some villages regardless of whether it was treated in an annual way or a biannual way," Gaynor said. "You can genuinely get same with less."

Their finding is significant because of how easily the disease spreads. Trachoma can be transmitted through touching one's eyes or nose after being in close contact with someone who is infected. It can also be spread through a towel or an article of clothing from a person who has trachoma. Even fli
'/>"/>

Contact: Leland Kim
leland.kim@ucsf.edu
415-502-6397
University of California - San Francisco
Source:Eurekalert  

0

GOOD

Page: 1 2

Related medicine news :

1. 2011 ASH Annual Meeting to highlight latest hematology research, clinical care breakthroughs
2. Cleveland researchers find possible breakthrough to relieve pain following spinal cord injury
3. Princeton technique puts chemistry breakthroughs on the fast track
4. 2 breakthrough innovations to address maternal and newborn deaths in Sub-Saharan Africa
5. Indevr launches breakthrough colorimetric detection for microarrays using core technology from CU
6. Ben-Gurion University of the Negev researchers achieve male fertility breakthrough
7. Breakthrough in understanding the genetics of high blood pressure
8. Northern Ireland company makes major breakthrough in cancer treatment
9. An important breakthrough at the IRCM associated with osteoporosis
10. Identification and management of breakthrough cancer pain remains a challenge
11. Childrens National researchers make breakthrough in understanding white matter development
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Breakthrough in treatment to prevent blindness
Breakthrough in treatment to prevent blindness
(Date:5/22/2012)... 22 (HealthDay News) -- The number of liver transplants ... new study finds. Researchers said one reason for ... has become more commonplace, and many of those livers ... aren,t healthy enough to attempt a transplant. Another reason ... a condition known as fatty liver disease, which is ...
(Date:5/22/2012)... 42/2010, which extends the smoking ban to public places, ... smokers (from 40.3% to 35.3%) and in consumption amongst ... women of all ages and occupations. , ... by the Society of Prevention of Ibermutuamur (accidents and ... consumption of tobacco in the working populating during the ...
(Date:5/22/2012)... -- Certain gene variants linked to prostate cancer ... tract symptoms, according to a new study. On ... protect against those symptoms, the study found. ... at Northwestern University in Chicago identified 38 genetic ... nearly 2,000 healthy, white men enrolled in a ...
(Date:5/22/2012)... ANN ARBOR, Mich. When thousands of psychiatrists attend ... they hear about research into drug treatments report overwhelmingly ... a new study published in the Journal of ... University of Michigan and Yale University, who analyzed the ... Psychiatric Association. , Of 278 studies presented at ...
(Date:5/22/2012)... the genome sequences of a dozen strains of ... resistant to vancomycin, an antibiotic of last resort. ... each strain, and identified shared features among the ... resistance and evade human immune defenses. , ... leading cause of hospital-acquired infections in the United ...
Breaking Medicine News(10 mins):Health News:U.S. Liver Transplants Declining 2Health News:5 percent of workers gave up smoking when the anti-tobacco law took effect 2Health News:Study Ties Genes to Lower Urinary Tract Symptoms, Prostate Cancer Risk 2Health News:Bias found in mental health drug research presented at major psychiatric meeting 2Health News:Bias found in mental health drug research presented at major psychiatric meeting 3Health News:Genomes show how Staph bacteria gain resistance to last-line drug 2
... Clear: It,s Time for Universal, Single-Payer ... ... California,Nurses Association/National Nurses Organizing Committee thanks Al Gore for,his forceful new ... this country desperately needs -- and that is,succeeding in nearly every ...
... 19 PulseLearning,(which was founded in 1999 with an ... second-hand computer set up in a child,s bedroom in ... growing IT company in,Ireland at the ,2007 Deloitte Technology ... in their eighth year, rank the 50 fastest,growing technology ...
... STERIS Corporation,(NYSE: STE ) today announced ... earnings release before the market opens on October ... a.m. Eastern time. The conference,call can be heard ... or via phone,by dialing 1-888-392-9976 in the United ...
... improve nutrition and physical activity, report says , ,* FRIDAY, Oct. ... with programs to promote the health and safety of students ... tobacco use -- there,s still room for significant improvement. ... and Programs Study (SHPPS) 2006 , issued Friday by the ...
... dialogue between parents and teens, TOPEKA, Kan., Oct. ... to prevent underage drinking with new 30-second,radio public service ... spots are timed to coincide with the busy fall ... and the end of November. "With teens heading ...
... 19 A recent study by Celent, a leading,financial ... York,Mellon as one of eight firms leading the way ... more efficiently handle transactions. Celent,s Healthcare Banking research ... of New York Mellon,s Treasury Services division to,apply its ...
Other Medicine News:Health News:National Nurses Movement Lauds Al Gore for Leadership on Single-Payer Healthcare 2Health News:PulseLearning (Founded in Child's Bedroom in an Irish Suburban Semi Eight Years Ago and Initially Run on a Second-Hand Computer) Today Named Fastest Growing IT Company in Ireland 2Health News:PulseLearning (Founded in Child's Bedroom in an Irish Suburban Semi Eight Years Ago and Initially Run on a Second-Hand Computer) Today Named Fastest Growing IT Company in Ireland 3Health News:PulseLearning (Founded in Child's Bedroom in an Irish Suburban Semi Eight Years Ago and Initially Run on a Second-Hand Computer) Today Named Fastest Growing IT Company in Ireland 4Health News:STERIS Corporation Announces Date of Fiscal 2008 Second Quarter Earnings Release and Conference Call 2Health News:STERIS Corporation Announces Date of Fiscal 2008 Second Quarter Earnings Release and Conference Call 3Health News:U.S. Schools Getting Better at Boosting Kids' Health 2Health News:U.S. Schools Getting Better at Boosting Kids' Health 3Health News:U.S. Schools Getting Better at Boosting Kids' Health 4Health News:Morrison Takes Aim at Underage Drinking in New Radio Campaign 2Health News:The Bank of New York Mellon Recognized as Change Agent Shaping the Direction of Healthcare Transaction Processing 2
(Date:5/22/2012)... NEW YORK, May 22, 2012  Fox Insurance Company, ... York, NY, announces the confirmation of a judgment in ... pharmacy benefit manager, in excess of $3.3 million, following ... negligence and breach of contract.  On May 21, 2012, ... Georgia, Atlanta Division, issued its decision confirming the arbitration ...
(Date:5/22/2012)... May 22, 2012 Sorbent Therapeutics, Inc. ... renal diseases, presented positive data from its Phase ... of 111 heart failure patients with chronic kidney ... as compared to placebo.    Data ... presented in an oral session at the Annual ...
(Date:5/22/2012)... Labs, Inc. (OTCQB/OTCBB: GOVX), an Atlanta-based biopharmaceutical firm ... Virus (HIV) infections, today announced that the NIH-funded ... for a Phase 1 trial for the company,s ... to the first generation (currently in ... inclusion of granulocyte-macrophage colony-stimulating factor (GM-CSF) as an ...
Breaking Medicine Technology:Judge Upholds $3.3 Million Judgment In Favor of Fox Insurance Company Against Former Pharmacy Benefit Manager 2Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study 2Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study 3HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 2HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 3HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 4Study shows nearly 1 3 of human genome is involved in gingivitis 11008 1Study shows nearly 1 3 of human genome is involved in gingivitis 11008 2Study shows nearly 1 3 of human genome is involved in gingivitis 11008 3Nutra Pharma Completes FDA Submission for Nyloxin OTC and Nyloxin Rx Over the Counter and Prescription Treatments for Chronic Pain 62729 1Nutra Pharma Completes FDA Submission for Nyloxin OTC and Nyloxin Rx Over the Counter and Prescription Treatments for Chronic Pain 62729 2Nutra Pharma Completes FDA Submission for Nyloxin OTC and Nyloxin Rx Over the Counter and Prescription Treatments for Chronic Pain 62729 3Hormonal Drugs Cool Hot Flashes From Prostate Cancer Therapy 62725 1Hormonal Drugs Cool Hot Flashes From Prostate Cancer Therapy 62725 2
... Years Post Surgery, VIENNA, Va., May 21, 2007 ... drug Multikine(R) was,shown to significantly increase long term ... and neck cancer patients. The data were,presented on ... of,the International Association of Oral Oncology in Amsterdam, ...
... Disease Week -, CAMBRIDGE, Mass., May 21, 2007 ... from a Phase 2 study in which,linaclotide accelerated ... constipation- predominant irritable bowel syndrome,(IBS-C). These data also ... of adverse events. Linaclotide is a first-in-class,compound currently ...
Other Medicine Technology:CEL-SCI Presents Long-Term Cancer Survival Data With Multikine 2CEL-SCI Presents Long-Term Cancer Survival Data With Multikine 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: